Filing Details

Accession Number:
0001213900-20-002005
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-01-28 16:07:38
Reporting Period:
2020-01-27
Accepted Time:
2020-01-28 16:07:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1522602 Cohbar Inc. CWBR Pharmaceutical Preparations (2834) 261299952
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1627971 Francis Jeffrey Biunno C/O Cohbar, Inc.
1455 Adams Drive, Suite 2050
Menlo Park CA 94025
Cfo, Treasurer And Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-01-27 5,000 $0.26 15,000 No 4 M Direct
Common Stock Disposition 2020-01-27 5,000 $2.51 10,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to buy) Disposition 2020-01-27 5,000 $0.00 5,000 $0.26
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
329,377 2024-04-09 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,000 Indirect By daughter
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
  2. Represents the weighted average sale price. The lowest price at which shares were sold was $2.42 and the highest price at which shares were sold was $2.51. The Reporting Person undertakes to provide upon request to the staff of the Securities Exchange Commission, the issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the ranges set forth in this footnote.
  3. Consists of previously reported shares indirectly beneficially owned by the Reporting Person.
  4. The options are fully vested.